Semiconductors Healthcare Sector

kneat.com

Market Cap: CA$629.6m

Designs, develops, and supplies software for data and document management within regulated environments in North America, Europe, and the Asia Pacific.

Sana Biotechnology

Market Cap: US$451.1m

A biotechnology company, focuses on utilizing engineered cells as medicines in the United States.

Personalis

Market Cap: US$450.5m

Develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally.

Paragon Care

Market Cap: AU$695.2m

Distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia.

MeiraGTx Holdings

Market Cap: US$449.3m

A clinical stage genetics medicines company, focusing on developing treatments for patients with serious diseases.

Bioventus

Market Cap: US$447.3m

A medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally.

Maze Therapeutics

Market Cap: US$443.7m

A clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of renal, cardiovascular, related metabolic diseases, and obesity in the United States.

Theravance Biopharma

Market Cap: US$440.0m

A biopharmaceutical company, develops and commercializes of medicines in the United States.

NeuroPace

Market Cap: US$437.9m

Operates as a medical device company in the United States.

Allergy Therapeutics

Market Cap: UK£328.9m

A commercial biotechnology company, focuses on the diagnosis and treatment of allergic disorders.

Standard BioTools

Market Cap: US$433.0m

Develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific.

SIGA Technologies

Market Cap: US$424.4m

A commercial-stage pharmaceutical company, focuses on the health security market in the United States.

Zevra Therapeutics

Market Cap: US$423.8m

A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.

Sage Therapeutics

Market Cap: US$422.7m

A biopharmaceutical company, develops and commercializes brain health medicines.

Knight Therapeutics

Market Cap: CA$582.8m

Focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America.

Northwest Biotherapeutics

Market Cap: US$413.2m

A biotechnology company, focuses on developing personalized immune therapies for cancer.

Oxford Biomedica

Market Cap: UK£309.5m

A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.

Prothena

Market Cap: US$409.6m

A late-stage clinical biotechnology company, focuses on discovery and development of novel therapies to treat diseases caused by protein dysregulation in the United States.

Amylyx Pharmaceuticals

Market Cap: US$407.6m

A clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States.

Zenas BioPharma

Market Cap: US$407.5m

A clinical-stage biopharmaceutical company, engages in the development and commercialization of transformative immunology-based therapies.

Tourmaline Bio

Market Cap: US$405.4m

Operates as a clinical biotechnology company that develops medicines for patients with life-altering immune and inflammatory diseases.

Celcuity

Market Cap: US$403.9m

A clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States.

Vitalhub

Market Cap: CA$562.0m

Provides technology and software solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally.

Precigen

Market Cap: US$402.8m

A discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases.

EyePoint Pharmaceuticals

Market Cap: US$402.5m

Engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases.

REGENXBIO

Market Cap: US$399.8m

A clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States.

Mereo BioPharma Group

Market Cap: US$397.5m

A biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally.

Australian Clinical Labs

Market Cap: AU$609.9m

Provides pathology diagnostic services in Australia.

Erasca

Market Cap: US$393.7m

A clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers.

Myriad Genetics

Market Cap: US$391.8m

A molecular diagnostic testing and precision medicine company, develops and provides molecular tests in the United States and internationally.

Senseonics Holdings

Market Cap: US$391.1m

A commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally.

PureTech Health

Market Cap: UK£292.1m

Engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States.

AngioDynamics

Market Cap: US$388.6m

A medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally.

LifeMD

Market Cap: US$388.6m

Operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States.

Verve Therapeutics

Market Cap: US$387.8m

A clinical-stage company, develops gene editing medicines for patients to treat cardiovascular disease in the United States.

Surmodics

Market Cap: US$387.4m

Provides performance coating technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally.